Cresco Labs (CRLBF) Change in Receivables (2020 - 2026)
Cresco Labs (CRLBF) reported Change in Receivables of -$406000.0 for Q1 2026, down 105.96% on a YoY basis from $6.8 million in Q1 2025, and up 98.06% quarter-over-quarter from -$20.9 million in Q4 2025.
Cresco Labs (CRLBF) Change in Receivables (2020 - 2026) Analysis & Trends
Cresco Labs has reported Change in Receivables for 7 years, with the latest figure at -$406000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 105.96% year-over-year to -$406000.0; the trailing twelve-month figure through Mar 2026 stood at -$19.2 million (down 392.58% YoY), and the FY2025 full-year result was -$12.0 million, down 795.32% from the prior year.
- Change in Receivables for Q1 2026 stood at -$406000.0, up from -$20.9 million in the prior quarter.
- The five-year high for Change in Receivables was $14.2 million in Q4 2023, with the low at -$20.9 million in Q4 2025.
- Historically, Change in Receivables has averaged -$1.2 million across 5 years, with a median of -$1.4 million in 2024.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 380.0% — and 2025, when it slumped 472.32%.
- Cresco Labs' Change in Receivables stood at -$5.1 million in 2022, then soared by 380.0% to $14.2 million in 2023, then tumbled by 60.45% to $5.6 million in 2024, then tumbled by 472.32% to -$20.9 million in 2025, then surged by 98.06% to -$406000.0 in 2026.
- The last three Change in Receivables figures came in at -$406000.0 (Q1 2026), -$20.9 million (Q4 2025), and -$3.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn | -406,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -406,000.00 |
| Mar 31, 2026 | -406,000.00 |
| Dec 31, 2025 | -20.90 Mn |
| Dec 31, 2025 | -20.90 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Jun 30, 2025 | 5.73 Mn |
| Jun 30, 2025 | 5.73 Mn |
| Mar 31, 2025 | 6.81 Mn |
| Mar 31, 2025 | 6.81 Mn |
| Dec 31, 2024 | 5.61 Mn |
| Dec 31, 2024 | 5.61 Mn |
| Sep 30, 2024 | -1.41 Mn |
| Sep 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -4.43 Mn |
| Jun 30, 2024 | -4.43 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | 14.20 Mn |
| Dec 31, 2023 | 14.20 Mn |